BUSINESS
March 10, 2012
Cooper Cos., which makes contact lenses, reported first-quarter earnings of $54.6 million, or $1.12 per share, up from $39.2 million, or 83 cents, a year ago. Analysts expected $1.04 per share. The California company also boosted its earnings guidance for 2012, from $4.80 to $5 per share, to as much as $5.15.
NEWS
January 25, 2012 | Linda Deutsch, AP Special Correspondent
The bizarre murder case against a man who assumed multiple identities including that of a Rockefeller is headed for trial and a lawyer for the defendant said he welcomes the chance to go before a jury. "He views this as a beginning, not an end," said attorney Jeffrey Denner after a judge ordered Christian Gerhartsreiter to be tried on a charge of murdering the son of his landlady a quarter century ago. Gerhartsreiter, a German immigrant who at times called himself Clark Rockefeller, Chris Chichester and Christopher Crowe, has pleaded innocent in the killing of John Sohus, a crime...
A&E
November 13, 2011 | Mark Feeney, Globe Staff
The popcorn is greasy, and I forgot to bring a Kleenex. A pill that's a bomb inside the stomach of a man inside The Embassy blows up. Eructations of flame, luxurious cauliflowers giganticize into motion. The entire 29-ft. screen is orange, is crackling flesh and brick bursting, blackening, smithereened. I unwrap a Dentyne and, while jouncing my teeth in rubber tongue-smarting clove, try with the 2-inch-wide paper to blot butter off my fingers.
BUSINESS
October 13, 2011 | By Associated Press
WASHINGTON - One of the largest eye care companies, CooperVision, is stepping up efforts to publicize its recall of 600,000 contact lenses after coming under pressure from federal regulators. CooperVision issued its second announcement in two months about the recall of Avaira Toric lenses linked to pain, red eye, and blurred vision. The company had focused its efforts on eye care professionals, but the Food and Drug Administration said a larger effort was needed to alert consumers.
LIFESTYLE
June 29, 2011
Johnson & Johnson on Tuesday announced another Tylenol recall due to a musty moldy odor linked to a trace chemical. The company’s McNeil Consumer Healthcare unit is recalling one product lot of Tylenol Extra Strength Caplets made in February 2009 and distributed in the U.S. The recall totals 60,912 bottles, each of which has 225 caplets. McNeil said it has received a small number of reports about the pills’ odor, which has been linked in past J&J recalls to the presence of trace amounts of “2,4,6-tribromoanisole.’’ TBA is a byproduct of a chemical...
BUSINESS
August 28, 2010 | Linda A. Johnson, Associated Press
TRENTON, N.J. — With Johnson & Johnson’s once-golden reputation tarnished by 11 recalls of medicines, contact lenses, and hip implants in as many months, its chief executive says he knows the company let consumers down. J&J plans a public campaign to help rebuild their trust, but not until after about 40 recalled nonprescription medicines are back on store shelves sometime early next year. In the meantime, the company is also doing everything possible “to make sure this never happens again,’’ chief executive Bill Weldon said yesterday.